Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants

Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants

PurposePlasma level of B-type natriuretic peptide (BNP), an emerging, sensitive, and specific biomarker of hemodynamically significant patent ductus arteriosus (PDA), rapidly decreases in infants receiving cyclooxygenase inhibitors for ductal closure. We investigated the usefulness of serial BNP mea...

Full description

Bibliographic Details
Main Authors:	Jeonghee Shin, Eun Hee Lee, Jee Hyun Lee, Byung Min Choi, Young Sook Hong
Format:	Article
Language:	English
Published:	Korean Pediatric Society 2017-06-01
Series:	Korean Journal of Pediatrics
Subjects:	B-type natriuretic peptide Ibuprofen Patent ductus arteriosus Preterm infant
Online Access:	http://kjp.or.kr/upload/pdf/kjped-60-175.pdf

Similar Items

Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
by: Mehdi Ghaderian, et al.
Published: (2019-01-01)

Ibuprofen and indomethacin for the closure of the patent ductus arteriosus
by: Gian Maria Pacifici

Evaluation of the Efficacy and Safety of Oral İbuprofen in the Treatment of Patent Ductus Arteriosus
by: Mehmet Kervancıoğlu, et al.
Published: (2005-01-01)

Different doses of ibuprofen in the treatment of patent ductus arteriosus: a randomized clinical trial
by: Jafari Fesharaki H, et al.
Published: (2012-11-01)

Comparison of two dose regimens of ibuprofen for the closure of patent ductus arteriosus in preterm newborns
by: Laura Vargas Dornelles, et al.
Published: (2016-05-01)

Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
by: Reham S Abd Al Hamid
Published: (2020-01-01)

Effect of oral Ibuprofen in ductus arteriosus closure in preterm infants
by: Mohagheghi P (MD), et al.
Published: (2010-06-01)

Comparison of gastrointestinal complications of paracetamol and ibuprofen in the management of infants with patent ductus arteriosus: A randomized clinical trial study
by: Gohar Shahmirzadi, et al.
Published: (2021-01-01)

Positive tendency toward synchronous use of acetaminophen and ibuprofen in treating patients with patent ductus arteriosus
by: Roya Oboodi, et al.
Published: (2020-09-01)

Ibuprofen and paracetamol for patent ductus arteriosus
by: Carlo Dani
Published: (2014-09-01)

Comparison of Therapeutic Effects and Side Effects of Oral Ibuprofen and Indomethacin on the Closure of Patent Ductus Arteriosus in Premature Infants
by: P Sadeghi-Moghaddam, et al.
Published: (2017-09-01)

Correlation of B-type natriuretic peptide levels and echocardiographic parameters in preterm infants with patent ductus arteriosus
by: Hyun Ah Jeong, et al.
Published: (2016-04-01)

Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety
by: Haşim Olgun, et al.
Published: (2017-02-01)

Efficacy and complications of oral ibuprofen and intravenous acetaminophen in closure of patent ductus arteriosus of preterm neonates
by: Semira Mehralizadeh, et al.
Published: (2019-11-01)

The efficacy and safety of oral paracetamol versus oral ibuprofen for patent ductus arteriosus closure in preterm neonates – A systematic review and meta-analysis
by: Raymond Pranata, et al.
Published: (2020-05-01)

Effect of ibuprofen for hemodynamically significant patent ductus arteriosus closure on the development of acute kidney injury in preterm infants
by: T.P. Borysova, et al.
Published: (2021-03-01)

Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
by: Caterina Coviello, et al.
Published: (2020-09-01)

Medical closure of patent ductus arteriosus does not reduce mortality and development of bronchopulmonary dysplasia in preterm infants
by: Demet Terek, et al.
Published: (2014-01-01)

Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis
by: Yingqi Xiao, et al.
Published: (2020-02-01)

Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
by: Mehdi Ghaderian, et al.
Published: (2019-01-01)

Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series
by: Ayumi Oshima, et al.
Published: (2020-01-01)

Pre-symptomatic prediction of morbitidies in preterm infants with patent ductus arteriosus by targeted neonatal echocardiography and brain-type natriuretic peptide
by: Yasser Elsayed, et al.
Published: (2016-08-01)

Perinatal risk factors of symptomatic preterm patent ductus arteriosus and secondary ligation
by: Jin A Lee, et al.
Published: (2020-08-01)

Comparison of oral ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants
by: Eun Mi Yang, et al.
Published: (2013-01-01)

Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
by: Cheng Han Lee, et al.
Published: (2012-12-01)

Ibuprofen vs. indomethacin for persistent ductus arteriosus closure in preterm infants
by: Deny Salverra Yosy, et al.
Published: (2013-06-01)

Platelet Count Might Be Associated With the Closure of Hemodynamically Significant Patent Ductus Arteriosus
by: Junyan Zhong, et al.
Published: (2021-10-01)

Subaortic membrane with patent ductus arteriosus
by: Nishes Basnet, et al.
Published: (2017-11-01)

Efficacy of Paracetamol in Closure of Ductus Arteriosus in Infants under 32 Weeks of Gestation
by: Ines Tofe, et al.
Published: (2018-02-01)

Surgical Treatment of Patent Ductus Arteriosus by Combined Ligation and ClippingSomchai Waikittipong
by: Somchai Waikittipong
Published: (2011-02-01)

IV Paracetamol versus Oral Ibuprofen for Closure of Patent Ductus Arteriosus in Preterm Neonates Admitted To a Tertiary Care Centre in North Karnataka, India- A Randomized Control Trial
by: Siddu Charki, et al.
Published: (2020-01-01)

Diameter of the ductus arteriosus as a predictor of patent ductus arteriosus (PDA)
by: Nowak Dariusz, et al.
Published: (2011-08-01)

Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
by: Jennifer L. Bell, et al.
Published: (2021-05-01)

The Comparison Between Intravenous Acetaminophen Versus Oral Ibuprofen in Preterm Newborns With Patent Ductus Arteriosus: A Clinical Trial
by: Behzad Mohammadpour Ahranjani, et al.
Published: (2021-01-01)

Association between Platelet Counts before and during Pharmacological Therapy for Patent Ductus Arteriosus and Treatment Failure in Preterm Infants
by: Hannes Sallmon, et al.
Published: (2018-03-01)

Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
by: Romaine Arlettaz
Published: (2017-06-01)

Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation
by: Jannatdoust Abdollah, et al.
Published: (2014-12-01)

Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021-02-01)

Intravenous Paracetamol and Patent Ductus Arteriosus Closure
by: Herlina Dimiati, et al.
Published: (2020-01-01)

Oral paracetamol in treatment of closure of patent ductus arteriosus in preterm neonates
by: B Jasani, et al.
Published: (2013-01-01)